Shukra Pharmaceuticals Limited's latest marketcap:
As of 07/09/2025, Shukra Pharmaceuticals Limited's market capitalization has reached $100.03 M. According to our data, Shukra Pharmaceuticals Limited is the 24730th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 100.03 M |
| Revenue (ttm) | 4.29 M |
| Net Income (ttm) | 1.12 M |
| Shares Out | 437.88 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 09/23/2024 |
| Earnings Date | 08/12/2025 |
Shukra Pharmaceuticals Limited's yearly market capitalization.
| Date | Market Cap(₹) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/09/2025 | ₹8.57 B | $100.03 M | 40.72% | 24730 |
| 12/31/2024 | ₹5.97 B | $69.76 M | 340.79% | 25684 |
| 12/29/2023 | ₹1.35 B | $16.28 M | 554.74% | 34810 |
| 12/30/2022 | ₹206.9 M | $2.5 M | 58.55% | 39862 |
| 12/30/2021 | ₹130.5 M | $1.75 M | 105.8% | 38925 |
| 12/31/2020 | ₹63.41 M | $867,446.58 | -16.24% | 36168 |
| 12/27/2019 | ₹75.7 M | $1.06 M | 20.87% | 33217 |
| 12/26/2018 | ₹62.63 M | $899,949.99 | -6.65% | 32242 |
| 12/29/2017 | ₹67.09 M | $1.05 M | -49.56% | 30960 |
| 12/20/2016 | ₹133 M | $1.96 M | 33.67% | 28260 |
Company Profile
About Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited is a leading pharmaceutical company engaged in the development, manufacturing, marketing, and export of a diverse range of drugs and dosage forms. Operating in India and internationally, the company serves the healthcare sector with high-quality pharmaceutical solutions.
Product Portfolio
The company offers a comprehensive range of pharmaceutical products, including:
- Macrolides & Quinolones
- Anti-bacterial, Anti-fungal & Anti-viral medications
- Anti-malarial & Anti-protozoal treatments
- Anti-depressants & Anti-manic drugs
- Anti-emetic & Anti-ulcer formulations
- Beta blockers & Diuretics
- Analgesics & Muscle relaxants
- Anti-tuberculosis & Vitamin products
- Antibiotics (Penicillin & Cephalosporin)
Company Background
Originally incorporated in 1993 as Relish Pharmaceuticals Limited, the company rebranded to Shukra Pharmaceuticals Limited in August 2016. Headquartered in Ahmedabad, India, the company has built a strong reputation in the pharmaceutical industry over the years.
Frequently Asked Questions
-
What is Shukra Pharmaceuticals Limited's (BOM-524632) current market cap?As of 07/09/2025, Shukra Pharmaceuticals Limited (including the parent company, if applicable) has an estimated market capitalization of $100.03 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Shukra Pharmaceuticals Limited (BOM-524632) rank globally by market cap?Shukra Pharmaceuticals Limited global market capitalization ranking is approximately 24730 as of 07/09/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.